Trial Details
COMPLETEDBasic Information
| Clinical ID | c3998 |
|---|---|
| Identifier | NCT01203631 |
| Trial Title | Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammation|Crohn's Disease |
| Interventions | DRUG: NNC 0142-0000-0002|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2011-02 |
|---|---|
| Primary Completion Date | 2013-05 |
| Completion Date | 2013-05 |